This inventor holds 6 USPTO granted patents and 2 published patent applications. Top assignee: Handa Oncology, LLC. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations by Shang Wei Qin
Introduction
Shang Wei Qin is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of oncology through his innovative work. His research focuses on improving the efficacy and safety of cancer treatments.
Latest Patents
Shang Wei Qin holds a patent for "Cabozantinib compositions and methods of use." This invention relates to oral compositions that comprise cabozantinib salts and at least one pharmaceutically acceptable excipient. The methods outlined in the patent aim to increase the oral bioavailability of cabozantinib while reducing the adverse events associated with its oral administration. Additionally, the invention includes methods for preparing cabozantinib lauryl sulfate salts.
Career Highlights
Shang Wei Qin is currently associated with Handa Oncology, LLC, where he continues to advance his research in oncology. His work is pivotal in developing new therapeutic options for cancer patients.
Collaborations
Some of his notable coworkers include Fang-Yu Liu and Kc Sung, who contribute to the collaborative efforts in research and development at Handa Oncology.
Conclusion
Shang Wei Qin's innovative contributions to oncology through his patent on cabozantinib compositions highlight his commitment to improving cancer treatment options. His work exemplifies the importance of research and collaboration in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile